ArticleNeuropsychiatric disease and treatment2025
The Impact of Plasma Homocysteine Level and Estimated Glomerular Filtration Rate on Neurological Function at Admission in Patients with Acute Ischemic Stroke: A Retrospective Cross-Sectional Study.
Article in Neuropsychiatric disease and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the effects of homocysteine (Hcy) and estimated glomerular filtration rate (eGFR) on neurological function in patients with ischemic stroke (IS) on admission. Methods: 248 IS patients admitted to the Third Affiliated Hospital of Heilongjiang University of Chinese Medicine from January 2023 to January 2025 were studied. Basic information, disease history, laboratory test indicators and other information of patients were recorded at admission. According to admission mRS scores, patients were divided into two groups: the control group with good neurological function (mRS 0-1) and the neurological dysfunction group (mRS 2-5). The relationship between Hcy and eGFR on the neurological function of IS patients at admission was analyzed using a multivariate logistic regression model and an additive interaction model. Results: Among 248 patients, there were 118 patients with neurological dysfunction and 130 patients with good neurological function. After adjusting for confounding factors, it was found that eGFR and Hcy were independent influencing factors of neurological function in IS patients on admission (P < 0.05). The risk of neurological dysfunction in patients with elevated Hcy and decreased eGFR on admission was 4.28 times higher than that in patients with both indicators normal [OR = 4.28 (95% CI2.62-7.24), P < 0.001)]. There was a significant negative correlation between HCY and eGFR, and Hcy and eGFR had an additive interaction effect on the risk of neurological dysfunction on admission (RERI = 2.02, 95% CI0.02-4.01; AP = 0.45, 95% CI0.13-0.79). Conclusion: Hcy and eGFR are the influencing factors of neurological dysfunction in IS patients, and the two are significantly negatively correlated with the risk of neurological dysfunction in IS patients, and there is an additive interaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.